Retractable Technologies RVP
NYSE RVP
$0.73 +0.00 (+0.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Retractable Technologies (RVP) Liabilities and Shareholders Equity (2010 - 2026)

Retractable Technologies' (RVP) quarterly Liabilities and Shareholders Equity came in at $137.6 million in Q1 2026, down 7.84% YoY from $149.3 million in Q1 2025, and down 3.53% on a QoQ basis from $142.6 million in Q4 2025.

Retractable Technologies (RVP) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Retractable Technologies (RVP) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $137.6 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity fell 7.84% year-over-year to $137.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $573.8 million (down 8.72% YoY) and the FY2025 annual result came in at $142.6 million, down 11.26% from the prior year.
  • Liabilities and Shareholders Equity fell to $137.6 million in Q1 2026, from $142.6 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $207.5 million in Q1 2022 to a low of $137.6 million in Q1 2026.
  • A 5-year average of $171.6 million and a median of $176.0 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity surged 49.89% — and 2025, when it decreased 15.15%.
  • Tracing RVP's Liabilities and Shareholders Equity over 5 years: stood at $195.7 million in 2022, then slipped by 8.17% to $179.7 million in 2023, then fell by 10.55% to $160.7 million in 2024, then retreated by 11.26% to $142.6 million in 2025, then fell by 3.53% to $137.6 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $137.6 million (Q1 2026), $142.6 million (Q4 2025), and $146.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 20.88 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 50.73 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn 31.10 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 8.97 Bn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 39.35 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 4.08 Bn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 14.24 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn 12.48 Bn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 19.79 Bn
10 Retractable Technologies 21.67 Mn -18.20 Mn 190,852.00 141.69 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 137.60 Mn
Dec 31, 2025 142.63 Mn
Sep 30, 2025 146.43 Mn
Jun 30, 2025 147.09 Mn
Mar 31, 2025 149.31 Mn
Dec 31, 2024 160.72 Mn
Sep 30, 2024 157.81 Mn
Jun 30, 2024 160.74 Mn
Mar 31, 2024 175.98 Mn
Dec 31, 2023 179.67 Mn
Sep 30, 2023 181.52 Mn
Jun 30, 2023 186.77 Mn
Mar 31, 2023 193.66 Mn
Dec 31, 2022 195.67 Mn
Sep 30, 2022 200.58 Mn
Jun 30, 2022 194.28 Mn
Mar 31, 2022 207.50 Mn
Dec 31, 2021 206.30 Mn
Sep 30, 2021 177.99 Mn
Jun 30, 2021 175.70 Mn